Hemifacial Spasm Clinical Presentation

  • Author: Steven Gulevich, MD; Chief Editor: Nicholas Lorenzo, MD   more...
 
Updated: Jun 11, 2010
 

History

Involuntary facial movement is the only symptom. Fatigue, anxiety, or reading may precipitate the movements.

  • Hemimasticatory spasm
    • Hemimasticatory spasm is analogous to hemifacial spasm and occurs with irritation to the motor trigeminal nerve.
    • This rare condition is a segmental myoclonus and presents with unilateral involuntary contractions of the trigeminally innervated muscles of mastication (usually the masseter).
    • Similar to hemifacial spasm, hemimasticatory spasm responds to treatment with medications and botulinum toxin.
    • However, less evidence exists that exploratory surgery benefits patients with this condition.
  • Myoclonic movements
    • Myoclonic movements affecting facial musculature also may arise from lesions at the brain or brainstem level.
    • These are distinguished from hemifacial spasm by the distribution of abnormal movements (more generalized, possibly bilateral) and possibly by electrodiagnostic evaluation.
    • Imaging studies may yield an underlying cause.
    • Central myoclonus responds to anticonvulsant management.
  • Oromandibular dystonia
    • Oromandibular dystonia (OMD) refers to dystonia affecting the lower facial musculature, predominantly the jaw, pharynx, and tongue.
    • When oromandibular dystonia occurs in conjunction with blepharospasm, the disorder is termed Meige syndrome.
    • Jaw-opening forms of oromandibular dystonia indicate primary involvement of the digastric and lateral pterygoid. Jaw-closing oromandibular dystonia involves the masseter, temporalis, and medial pterygoid.
    • Jaw deviation, indicating predominant involvement of the lateral pterygoid, is rare.
    • Botulinum toxin is the preferred treatment for oromandibular dystonia and is most effective in the jaw-closure type.
    • Medications seldom yield acceptable results. When medications must be used, employ the same agents as for blepharospasm.
    • Because of the risk of aspiration, never inject botulinum toxin into the tongue.
  • Craniofacial tremor
    • Craniofacial tremor may occur in association with essential tremor, Parkinson disease, thyroid dysfunction, or electrolyte disturbance.
    • It occurs rarely in isolation.
    • Focal motor seizures must occasionally be distinguished from other facial movement disorders, particularly hemifacial spasm.
    • Postictal weakness and greater involvement of the lower face are distinguishing features of focal motor seizures.
  • Facial chorea
    • Facial chorea occurs in the context of a systemic movement disorder (eg, Huntington disease, Sydenham chorea).
    • Chorea is a random, flowing, nonpatterned set of movements.
    • A related disorder, spontaneous orofacial dyskinesia of the elderly, is observed primarily in the edentulous. It usually responds to proper fitting of dentures.
  • Tics
    • Facial tics are brief, repetitive, coordinated, semipurposeful movements of grouped facial and neck muscles.
    • Tics may occur physiologically or in association with diffuse encephalopathy.
    • Some medications (ie, anticonvulsants, caffeine, methylphenidate, antiparkinsonian agents) are associated with producing tics.
    • Single, repetitive, stereotyped movements (eg, repetitive grimacing, throat clearing, vocalizations) define a simple tic disorder.
  • Facial myokymia
    • Facial myokymia appears as vermicular twitching under the skin, often with a wavelike spread.
    • This is distinguished from other abnormal facial movements by characteristic electromyogram discharges presenting as brief, repetitive bursts of motor unit potentials firing at 2-60 Hz interrupted by periods of silence of up to a few seconds.
    • Facial myokymia may occur with any brainstem process. Severe cases may benefit from botulinum toxin.
    • Most cases are idiopathic and resolve without treatment over several weeks.
Next

Physical

  • The only physical finding in hemifacial spasm is involuntary facial movements.
  • Spontaneous hemifacial spasm manifests with facial spasms that represent myoclonic jerks and are analogous to segmental myoclonus, which may affect other body regions.
  • Postparalytic hemifacial spasm (following facial nerve trauma such as Bell palsy) manifests as facial synkinesis and contracture.
Previous
Next

Causes

  • Idiopathic
  • Vascular compression
  • Facial nerve compression by mass
  • Brainstem lesion such as stroke or multiple sclerosis plaque
  • Secondary to trauma or Bell palsy
Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Steven Gulevich, MD  Centennial Medical Center, Centennial, Colorado

Steven Gulevich, MD is a member of the following medical societies: American Academy of Neurology and Colorado Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Stephen A Berman, MD, PhD, MBA  Professor of Neurology, University of Central Florida College of Medicine

Stephen A Berman, MD, PhD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Glenn Lopate, MD  Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Director of Neurology Clinic, St Louis ConnectCare; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Ortho McNeil Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Speaking, consulting

Chief Editor

Nicholas Lorenzo, MD  Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants

Nicholas Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology

Disclosure: Nothing to disclose.

References
  1. Mauriello JA, Leone T, Dhillon S, et al. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg. Aug 1996;98(3):213-6. [Medline].

  2. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. Aug 1990;53(8):633-9. [Medline].

  3. Colosimo C, Chianese M, Giovannelli M, et al. Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neurol Neurosurg Psychiatry. May 2003;74(5):687. [Medline].

  4. Adler CH, Zimmerman RA, Savino PJ, et al. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol. Oct 1992;32(4):502-6. [Medline].

  5. Campos-Benitez M, Kaufmann AM. Neurovascular compression findings in hemifacial spasm. J Neurosurg. Sep 2008;109(3):416-20. [Medline].

  6. Cruccu G, Inghilleri M, Berardelli A, et al. Pathophysiology of hemimasticatory spasm. J Neurol Neurosurg Psychiatry. Jan 1994;57(1):43-50. [Medline].

  7. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol. Jan 1992;239(1):5-8. [Medline].

  8. Jannetta PJ, Abbasy M, Maroon JC, et al. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg. Sep 1977;47(3):321-8. [Medline].

  9. Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. CMAJ. Nov 1 1988;139(9):837-44. [Medline].

  10. Moller AR. The cranial nerve vascular compression syndrome: I. A review of treatment. Acta Neurochir (Wien). 1991;113(1-2):18-23. [Medline].

  11. Moller AR. The cranial nerve vascular compression syndrome: II. A review of pathophysiology. Acta Neurochir (Wien). 1991;113(1-2):24-30. [Medline].

  12. Reimer J, Gilg K, Karow A, et al. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand. Jan 2005;111(1):64-70. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.